Despite recent sharp criticism and a $ 650 million settlement, hundreds of thousands of consumers with atrial fibrillation continue to take the blood thinner.
Well
Weighing Pradaxa’s Risks
Despite recent sharp criticism and a $ 650 million settlement, hundreds of thousands of consumers with atrial fibrillation continue to take the blood thinner.
Well
Weighing Pradaxa’s Risks
No comments:
Post a Comment